BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1322426)

  • 1. Monoclonality of corticotroph macroadenomas in Cushing's disease.
    Gicquel C; Le Bouc Y; Luton JP; Girard F; Bertagna X
    J Clin Endocrinol Metab; 1992 Aug; 75(2):472-5. PubMed ID: 1322426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis.
    Schulte HM; Oldfield EH; Allolio B; Katz DA; Berkman RA; Ali IU
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1302-8. PubMed ID: 1720126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
    Bertagna X
    J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal composition of human adrenocortical neoplasms.
    Beuschlein F; Reincke M; Karl M; Travis WD; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
    Cancer Res; 1994 Sep; 54(18):4927-32. PubMed ID: 7915195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease.
    Biller BM; Alexander JM; Zervas NT; Hedley-Whyte ET; Arnold A; Klibanski A
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1303-9. PubMed ID: 1358909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathology and pathogenesis of pituitary corticotroph adenoma].
    Trouillas J
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
    Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
    Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal origin of pituitary adenomas.
    Herman V; Fagin J; Gonsky R; Kovacs K; Melmed S
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1427-33. PubMed ID: 1977759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of pituitary Cushing's syndrome. Pituitary versus hypothalamic.
    Biller BM
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):547-54. PubMed ID: 7805653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome.
    AssiƩ G; Bahurel H; Coste J; Silvera S; Kujas M; DuguƩ MA; Karray F; Dousset B; Bertherat J; Legmann P; Bertagna X
    J Clin Endocrinol Metab; 2007 Jan; 92(1):172-9. PubMed ID: 17062771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus.
    Huizenga NA; de Lange P; Koper JW; Clayton RN; Farrell WE; van der Lely AJ; Brinkmann AO; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1998 Mar; 83(3):917-21. PubMed ID: 9506748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of leukemia inhibitory factor-receptor (LIF-R) in ACTH-secreting pituitary adenomas.
    Heutling D; Dieterich KD; Buchfelder M; Lehnert H
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):458-61. PubMed ID: 15372367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
    Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV
    Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
    J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoelectron microscopical study on human pituitary corticotrophic adenomas].
    Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 1990 Jun; 19(2):100-2. PubMed ID: 2167773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.